Walking Strategies in Usual Locomotion of Lower Limb Amputees
NCT ID: NCT05420623
Last Updated: 2025-01-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
80 participants
OBSERVATIONAL
2021-12-16
2023-12-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main aim of this study is to determinate the walking strategies of lower limb amputees in several locomotion tasks on daily life. Then, the investigators study the evolution of these walking strategies after a gait training and over time.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of Locomotor Expectations for Ascending/descending Slope and Stairs in Patients with Limb Amputations
NCT04030650
Assessment of Accelerometric Measurement Devices for Gait Analysis
NCT01522690
Gait Stability of People With Lower-limb Amputations
NCT00915109
Walking Characteristics of Patients With Amputation
NCT05595291
Does Improved Ability to Achieve Single Leg Stance Lead to a More Efficient Gait Pattern in Adults With Acquired Brain Injury?
NCT04062149
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The subjects in the control group will be recruited from among the carers of patients undergoing rehabilitation and from among volunteers recruited by means of posters in the establishments of the HOPALE Foundation in Berck.
Once the eligibility criteria have been checked, a quantified gait analysis and functional tests will be carried out: the 6-minute walk test (T6M) and the Time Up and Go test (TUG). They will complete a single visit lasting approximately 1 hour and 30 minutes.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Amputees patients
No interventions assigned to this group
control group: non-amputees
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Unilateral amputation,
* Aged 18 or over,
* Mobility level equal to or greater than 2 (according to Medicare Functional Classification Levels),
* Subject who has given his or her free and informed consent.
* Definitive apparatus less than one month old,
* Contraindications for walking,
* Presence of a major neurocognitive disorder reported in the medical record (as mentioned in the DMS-5): acquired, significant and progressive reduction in abilities in one or more cognitive domains, significant enough to no longer be able to perform activities of daily living alone (loss of autonomy)
* Cognitive disorders reported in the medical file,
* Subject under guardianship, curatorship or protective measure,
* Pregnant or lactating woman.
\- Able to walk 50m alone.
* Contraindication to effort,
* Cognitive disorders known by the subject, causing difficulties in performing tasks related to activities of daily living
* Any history of neurological or orthopedic origin likely to limit the quality of walking,
* Notion of trauma on the musculoskeletal system less than 3 months (sprain type, muscle injury, etc.),
* Subject under guardianship, curatorship or protective measure,
* Pregnant or lactating woman.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Lille Catholic University
OTHER
FondationbHopale
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Frederic CHARLATE
Role: PRINCIPAL_INVESTIGATOR
Fondation Hopale
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fondation HOPALE - Centre de rééducation Jacques CALVE
Berck, Hauts-de-France, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HOP-RIPH2-21-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.